Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$677M |
| 2 |
AGN
Allergan plc
AGN
|
+$437M |
| 3 |
Qualcomm
QCOM
|
+$387M |
| 4 |
lululemon athletica
LULU
|
+$366M |
| 5 |
NVIDIA
NVDA
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Under Armour
UAA
|
+$1.03B |
| 2 |
Abbott
ABT
|
+$767M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$627M |
| 4 |
Meta Platforms (Facebook)
META
|
+$520M |
| 5 |
Nike
NKE
|
+$454M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.09% |
| 2 | Healthcare | 16.64% |
| 3 | Technology | 14.97% |
| 4 | Communication Services | 12.63% |
| 5 | Financials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Korn Ferry
KFY
$3.97B
| $45.1M | 0.05% |
2,178,476
+188,949
| +9% | +$5.17M |
|
|
EQGP
302
DELISTED
EQGP Holdings, LP
EQGP
| $44.5M | 0.05% |
1,747,463
-47,810
| -3% | -$1.2M |
|
303
Darling Ingredients
DAR
$10.1B
| $44.4M | 0.05% |
2,978,799
-317,007
| -10% | -$4.58M |
|
|
MDVN
304
DELISTED
MEDIVATION, INC.
MDVN
| $44M | 0.05% |
+730,097
| New | +$41.4M |
|
305
Louisiana-Pacific
LPX
$4.98B
| $44M | 0.05% |
2,535,558
-14,488
| -0.6% | -$255K |
|
|
EE
306
DELISTED
El Paso Electric Company
EE
| $43.7M | 0.05% |
924,671
-1,546
| -0.2% | -$69.9K |
|
|
WCC
307
WESCO International
WCC
$15.5B
| $43.6M | 0.05% |
847,712
-338,394
| -29% | -$19M |
|
|
ZOES
308
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $43.4M | 0.05% |
1,196,637
-294,044
| -20% | -$11M |
|
309
Thermo Fisher Scientific
TMO
$196B
| $43M | 0.05% |
290,671
-8,148
| -3% | -$1.2M |
|
310
W.R. Berkley
WRB
$27.1B
| $42.7M | 0.05% |
2,403,324
+318,995
| +15% | +$5.31M |
|
311
Guidewire Software
GWRE
$12.4B
| $42.5M | 0.05% |
688,010
+123,881
| +22% | +$7.14M |
|
312
Bath & Body Works
BBWI
$4.13B
| $42.4M | 0.05% |
782,118
-5,420,661
| -87% | -$317M |
|
313
NN Inc
NNBR
$268M
| $42.4M | 0.05% |
3,032,909
-1,502
| -0% | -$23.6K |
|
|
HOT
314
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $42M | 0.05% |
568,495
+4,299
| +0.8% | +$330K |
|
315
Pinnacle West Capital
PNW
$12.9B
| $41.9M | 0.05% |
+517,087
| New | +$38.6M |
|
316
Five Below
FIVE
$11.3B
| $41.7M | 0.05% |
898,161
-6,272
| -0.7% | -$262K |
|
|
DBD
317
DELISTED
Diebold Nixdorf Incorporated
DBD
| $41.7M | 0.05% |
1,678,640
-361,532
| -18% | -$9.31M |
|
|
AGN.PRA
318
DELISTED
Allergan plc
AGN.PRA
| $40.3M | 0.04% |
48,396
+20,925
| +76% | +$17.5M |
|
319
Travere Therapeutics
TVTX
$5.16B
| $40.3M | 0.04% |
2,264,275
-833
| -0% | -$13.5K |
|
320
The GEO Group
GEO
$4.09B
| $40.3M | 0.04% |
1,767,272
-600,483
| -25% | -$13.2M |
|
321
Molina Healthcare
MOH
$12B
| $40.3M | 0.04% |
806,821
-16,031
| -2% | -$857K |
|
322
Varonis Systems
VRNS
$5.45B
| $40M | 0.04% |
5,001,906
+286,317
| +6% | +$2.1M |
|
323
Marathon Petroleum
MPC
$92.1B
| $39.8M | 0.04% |
1,048,709
-34,176
| -3% | -$1.26M |
|
|
BLUE
324
DELISTED
bluebird bio
BLUE
| $38M | 0.04% |
67,786
+92
| +0.1% | +$52.1K |
|
|
MPSX
325
DELISTED
Multi Packaging Solutions Intl.
MPSX
| $37.2M | 0.04% |
2,784,782
+1,572,933
| +130% | +$24.5M |
|
Similar funds
Jennison Associates's Q2 2016 Portfolio in Review
As of Q2 2016, Jennison Associates held 691 positions worth $91.1B, down 4.3% from $95.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jennison Associates withdrew a net $4.67B in Q2 2016, closing 61 positions and reducing 333 holdings. Its most notable exit was MCGRAW-HILL FINANCIAL INC COM, an estimated $627M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Jennison Associates opened a new position in S&P Global worth $677M.
- Jennison Associates's largest Q2 2016 buy was S&P Global: 6,307,763 shares worth $677M.
- Jennison Associates added most to Allergan plc in Q2 2016, an estimated $437M increase.
- Jennison Associates's biggest Q2 2016 reduction was Under Armour, cutting an estimated $1.03B.
- Jennison Associates fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $627M.
- Jennison Associates's ten largest holdings make up 23% of its $91.1B portfolio in Q2 2016.
- Jennison Associates opened 83 new positions and closed 61 in Q2 2016.
- Jennison Associates's portfolio value fell 4.3% quarter-over-quarter to $91.1B.
Based on Jennison Associates's 13F filing for Q2 2016, filed 3 Aug 2016.